Total Payments
$6,946
2024 Payments
$1,459
Companies
39
Transactions
439
Medicare Patients
2,690
Medicare Billing
$170,092

Payment Breakdown by Category

Food & Beverage$6,896 (99.3%)
Education$50.00 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,896 437 99.3%
Education $50.00 2 0.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $964.98 72 $0 (2024)
GlaxoSmithKline, LLC. $896.06 56 $0 (2024)
Novo Nordisk Inc $881.64 63 $0 (2024)
PFIZER INC. $534.01 29 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $475.34 30 $0 (2024)
AstraZeneca Pharmaceuticals LP $334.47 21 $0 (2024)
Lilly USA, LLC $319.43 18 $0 (2024)
Amgen Inc. $298.10 18 $0 (2024)
Janssen Pharmaceuticals, Inc $274.82 16 $0 (2024)
Novartis Pharmaceuticals Corporation $206.15 12 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,459 90 ABBVIE INC. ($299.92)
2023 $1,007 53 GlaxoSmithKline, LLC. ($230.67)
2022 $1,572 94 ABBVIE INC. ($315.29)
2021 $807.61 57 AbbVie Inc. ($299.68)
2020 $421.93 29 Novo Nordisk Inc ($176.73)
2019 $482.99 37 Novo Nordisk Inc ($147.50)
2018 $1,042 68 PFIZER INC. ($208.67)
2017 $153.94 11 Novo Nordisk Inc ($36.42)

All Payment Transactions

439 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.55 General
Category: RESPIRATORY
12/11/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $15.36 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.54 General
Category: Respiratory
12/05/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $20.29 General
Category: RESPIRATORY
12/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.37 General
Category: NEUROSCIENCE
12/02/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $19.31 General
Category: UROLOGY
11/22/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $3.86 General
Category: RESPIRATORY
11/22/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $1.96 General
Category: RESPIRATORY
11/22/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $0.85 General
Category: RESPIRATORY
11/20/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $22.01 General
Category: Inflammation
11/20/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $21.39 General
Category: Diabetes
11/13/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $18.98 General
Category: Neuroscience
11/11/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $16.29 General
Category: Diabetes
11/07/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $22.50 General
Category: Cardio-renal
11/05/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $14.66 General
11/05/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $5.08 General
Category: NEUROSCIENCE
11/04/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $19.14 General
Category: RESPIRATORY
11/04/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $0.61 General
Category: RESPIRATORY
11/01/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $15.71 General
Category: Diabetes Care
10/30/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $16.10 General
Category: PAIN
10/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.67 General
Category: NEUROSCIENCE
10/29/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.52 General
Category: NEUROSCIENCE
10/29/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.18 General
Category: NEUROSCIENCE
10/23/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $18.18 General
Category: Inflammation
10/16/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $34.81 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 736 1,110 $187,483 $43,418
2022 15 751 1,071 $164,899 $38,505
2021 14 583 678 $95,058 $45,626
2020 13 620 905 $111,526 $42,544
Total Patients
2,690
Total Services
3,764
Medicare Billing
$170,092
Procedure Codes
55

All Medicare Procedures & Services

55 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 163 473 $110,022 $20,528 18.7%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 18 18 $5,580 $5,068 90.8%
90662 Influenza vaccine split virus, preservative free Office 2023 71 71 $9,230 $5,028 54.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 143 143 $32,461 $4,977 15.3%
G0008 Administration of influenza virus vaccine Office 2023 75 75 $5,625 $2,213 39.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 46 52 $9,400 $1,373 14.6%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 30 36 $6,120 $1,246 20.4%
87400 Detection test by immunoassay technique for influenza virus Office 2023 22 52 $2,600 $719.94 27.7%
G0009 Administration of pneumococcal vaccine Office 2023 24 24 $1,800 $708.24 39.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 61 63 $2,394 $528.28 22.1%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2023 22 28 $868.00 $453.60 52.3%
0124A Adm sarscv2 bvl 30mcg/.3ml a Office 2023 11 11 $935.00 $432.85 46.3%
81003 Automated urinalysis test Office 2023 50 64 $448.00 $140.80 31.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 168 434 $92,664 $17,934 19.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 141 141 $32,007 $7,869 24.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 36 46 $13,850 $3,276 23.7%
90662 Influenza vaccine split virus, preservative free Office 2022 62 62 $2,750 $2,518 91.6%
G0008 Administration of influenza virus vaccine Office 2022 67 68 $5,025 $1,940 38.6%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 25 29 $4,930 $1,012 20.5%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 22 48 $1,488 $782.52 52.6%
0124A Fee covid-19 vac 13 res Office 2022 16 16 $1,360 $603.52 44.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 34 35 $5,384 $592.09 11.0%
0054A Adm sarscv2 30mcg trs-sucr b Office 2022 15 15 $1,275 $571.25 44.8%
0134A Fee covid-19 vac 14 res Office 2022 14 14 $1,190 $528.08 44.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 41 42 $1,481 $360.55 24.3%

About Dr. Iram Mall, M.B.B.S

Dr. Iram Mall, M.B.B.S is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1538573514.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iram Mall, M.B.B.S has received a total of $6,946 in payments from pharmaceutical and medical device companies, with $1,459 received in 2024. These payments were reported across 439 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,896).

As a Medicare-enrolled provider, Mall has provided services to 2,690 Medicare beneficiaries, totaling 3,764 services with total Medicare billing of $170,092. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.

Practice Information

Products in Payments

  • TRELEGY ELLIPTA (Drug) $698.91
  • UBRELVY (Drug) $521.56
  • Saxenda (Drug) $375.49
  • JARDIANCE (Drug) $351.20
  • QULIPTA (Drug) $340.14
  • Ozempic (Drug) $333.71
  • NURTEC ODT (Drug) $293.07
  • ELIQUIS (Drug) $226.98
  • FARXIGA (Drug) $219.58
  • XARELTO (Drug) $198.97
  • MOUNJARO (Drug) $146.73
  • JANUVIA (Drug) $140.93
  • VRAYLAR (Drug) $137.50
  • ZENPEP (Drug) $137.20
  • Otezla (Drug) $134.01
  • XIFAXAN (Drug) $131.99
  • LEQVIO (Drug) $125.84
  • SHINGRIX (Biological) $116.89
  • CHANTIX (Drug) $115.55
  • EUCRISA (Drug) $110.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Albany